Directorio de personas
Diego Arango Del Corro

Diego Arango Del Corro

Grado: Doctor/a


darango(ELIMINAR)@irblleida.cat

ResearcherID: http://www.researcherid.com/rid/M-5667-2016

Grupos

Publicaciones

  • Fourniols T; Maggio V; Rafael D; Colaco A; García Vidal E; Lopes A; Schwartz S; Martínez-Barriocanal Á; Preat V; Arango D

    Colorectal cancer inhibition by BET inhibitor JQ1 is MYC-independent and not improved by nanoencapsulation.

    EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS 171 39-49. .

    [doi:10.1016/j.ejpb.2021.10.017]

  • Giralt, I; Gallo-Oller, G; Navarro, N; Zarzosa, P; Pons, G; Magdaleno, A; Segura, MF; Sabado, C; Hladun, R; Arango, D; Sánchez de Toledo J; Moreno, L; Gallego, S; Roma, J

    Dickkopf-1 Inhibition Reactivates Wnt/ß-Catenin Signaling in Rhabdomyosarcoma, Induces Myogenic Markers In Vitro and Impairs Tumor Cell Survival In Vivo.

    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 22 -. .

    [doi:10.3390/ijms222312921]

  • Bazzocco S; Dopeso H; Martínez-Barriocanal Á; Anguita E; Nieto R; Li J; García-Vidal E; Maggio V; Rodrigues P; de Marcondes PG; Schwartz S Jr; Aaltonen LA; Sánchez A; Mariadason JM; Arango D

    Identification of ZBTB18 as a novel colorectal tumor suppressor gene through genome-wide promoter hypermethylation analysis.

    Clinical Epigenetics 13 88-88. .

    [doi:10.1186/s13148-021-01070-0]

  • Andrade F; Rafael D; Vilar-Hernández M; Montero S; Martínez-Trucharte F; Seras-Franzoso J; Díaz-Riascos ZV; Boullosa A; García-Aranda N; Cámara-Sánchez P; Arango D; Nestor M; Abasolo I; Sarmento B; Schwartz S

    Polymeric micelles targeted against CD44v6 receptor increase niclosamide efficacy against colorectal cancer stem cells and reduce circulating tumor cells in vivo.

    JOURNAL OF CONTROLLED RELEASE 331 198-212. .

    [doi:10.1016/j.jconrel.2021.01.022]

  • Overeem AW; Li Q; Qiu YL; Carton-Garciá F; Leng C; Klappe K; Dronkers J; Hsiao NH; Wang JS; Arango D; van IJzendoorn SCD

    A molecular mechanism underlying genotype-specific intrahepatic cholestasis resulting from MYO5B mutations.

    Hepatology 72 213-229. .

    [doi:10.1002/hep.31002]

  • Montanuy, H; Martinez-Barriocanal, A; Antonio Casado J; Rovirosa, L; Ramirez, MJ; Nieto, R; Carrascoso-Rubio, C; Riera, P; Gonzalez, A; Lerma, E; Lasa, A; Carreras-Puigvert, J; Helleday, T; Bueren, JA; Arango, D; Minguillon, J; Surralles, J

    Gefitinib and Afatinib Show Potential Efficacy for Fanconi Anemia-Related Head and Neck Cancer.

    CLINICAL CANCER RESEARCH 26 3044-3057. .

    [doi:10.1158/1078-0432.CCR-19-1625]

  • Montero S; Seras-Franzoso J; Andrade F; Martinez-Trucharte F; Vilar-Hernández M; Quesada M; Xandri H; Arango D; Abasolo I; Rafael D; Schwartz S

    Intracellular Delivery of Anti-SMC2 Antibodies against Cancer Stem Cells.

    Pharmaceutics 12 -. .

    [doi:10.3390/pharmaceutics12020185]

  • Gener P; Montero S; Xandri-Monje H; Díaz-Riascos ZV; Rafael D; Andrade F; Martínez-Trucharte F; González P; Seras-Franzoso J; Manzano A; Arango D; Sayós J; Abasolo I; Schwartz S

    Zileuton™ loaded in polymer micelles effectively reduce breast cancer circulating tumor cells and intratumoral cancer stem cells.

    Nanomedicine-Nanotechnology Biology and Medicine 24 102106-102106. .

    [doi:10.1016/j.nano.2019.102106]

  • Martinez-Barriocanal, A; Arango, D; Dopeso, H

    PVT1 Long Non-coding RNA in Gastrointestinal Cancer.

    Frontiers in oncology 10 38-38. .

    [doi:10.3389/fonc.2020.00038]

  • Forteza R; Ahsan MK; Cartón-García F; Arango D; Ameen NA; Salas PJ

    Glucocorticoids and myosin5b loss of function induce heightened PKA signaling in addition to membrane traffic defects.

    MOLECULAR BIOLOGY OF THE CELL 30 3076-3089. .

    [doi:10.1091/mbc.E18-07-0415]

  • Leng C; Overeem AW; Cartón-Garcia F; Li Q; Klappe K; Kuipers J; Cui Y; Zuhorn IS; Arango D; van IJzendoorn SCD

    Loss of MYO5B expression deregulates late endosome size which hinders mitotic spindle orientation.

    Plos Biology 17 -. .

    [doi:10.1371/journal.pbio.3000531]

  • Ruiz de Porras V; Bystrup S; Cabrero-de Las Heras S; Musulén E; Palomero L; Alonso MH; Nieto R; Arango D; Moreno V; Queralt C; Manzano JL; Layos L; Bugés C; Martinez-Balibrea E

    Tumor Expression of Cyclin-Dependent Kinase 5 (Cdk5) Is a Prognostic Biomarker and Predicts Outcome of Oxaliplatin-Treated Metastatic Colorectal Cancer Patients.

    Cancers 11 -. .

    [doi:10.3390/cancers11101540]

Proyectos

  • Antioxidant treatment as a novel therapeutic option for microvillus inclusion disease. ARMED
  • Nueva estrategia terapéutica para ael cáncer gástrico basada en la modulación de la señalización de RHOA
  • Desarrollo de nanosistemas de marcaje de CXCR4 mediante radiosondas para la imagen molecular de células tumorales y del microambiente tumoral
  • Identificación de nuevos biomarcadores de respuesta a los compuestos regorafenib y TAS-102 en pacientes con cáncer colorrectal.
  • Targeting tumor microevironment by a translational multivalent nanomedicine: towards an effective anticancer combination immunotherapy